CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Memory and Organizational Aid +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00105612
NCT00105612N/ACompleted
CompareCT.gov

Improving Informed Consent in Alzheimer's Disease Research

National Institute on Aging (NIA)·interventional·Posted Mar 16, 2005·Updated Dec 29, 2009

In Brief

A clinical study evaluating Memory and Organizational Aid and Standard Informed Consent Process for Alzheimer's Disease and Aging. Completed, across 1 site.

Detailed Summary

The purpose of this trial is to test whether a memory and organizational aid in the form of a document that summarizes and simplifies a study's key points can improve the decision-making abilities and competency of mild to early moderate Alzheimer's disease (AD) patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAlzheimer's Disease, Aging
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 16, 2005
Enrollment StartSep 1, 2004
Primary CompletionMar 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 21.3 years ago

Interventions

Memory and Organizational Aiddevice

Standard Informed Consent Processbehavioral

The informed consent protocol for a hypothetical early-phase drug trial will be administered by a trained interviewer in the patient's home